Lauren A Beslow1, Rebecca N Ichord2, Melissa C Gindville3, Jonathan T Kleinman4, Rachel A Bastian2, Sabrina E Smith5, Daniel J Licht2, Argye E Hillis6, Lori C Jordan3. 1. Departments of Pediatrics and Neurology, Yale University School of Medicine, New Haven, Connecticut. 2. Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 3. Division of Child Neurology, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee. 4. Stanford Stroke Center, Palo Alto, California. 5. Division of Pediatric Neurology, Kaiser Permanente Oakland Medical Center, Oakland, California. 6. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
IMPORTANCE: Hematoma expansion is the only modifiable predictor of outcome in adult intracerebral hemorrhage; however, the frequency and clinical significance of hematoma expansion after childhood intracerebral hemorrhage are unknown. OBJECTIVE: To assess the frequency and extent of hematoma expansion in children with nontraumatic intracerebral hemorrhage. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational cohort study at 3 tertiary care pediatric hospitals. Children (≥ 37 weeks' gestation to 18 years) with nontraumatic intracerebral hemorrhage were enrolled in a study from 2007 to 2012 focused on predictors of outcome. For this planned substudy of hematoma expansion, neonates 28 days or younger and participants with isolated intraventricular hemorrhage were excluded. Children with 2 head computed tomography (CT) scans within 48 hours were evaluated for hematoma expansion and were compared with children with only 1 head CT scan. Consent for the primary cohort was obtained from 73 of 87 eligible participants (84%); 41 of 73 children enrolled in the primary cohort met all inclusion/exclusion criteria for this substudy, in whom 22 had 2 head CT scans obtained within 48 hours that could be evaluated for hematoma expansion. Within our substudy cohort, 21 of 41 (51%) were male, 25 of 41 (61%) were white, 16 of 41 (39%) were black, and median age was 7.7 years (interquartile range, 2.0-13.4 years). MAIN OUTCOME AND MEASURE: Primary outcome was prevalence of hematoma expansion. RESULTS: Of 73 children, 41 (56%) met inclusion criteria, and 22 (30%) had 2 head CT scans to evaluate expansion. Among these 22 children, median time from symptom onset to first CT was 2 hours (interquartile range, 1.3-6.5 hours). Median baseline hemorrhage volume was 19.5 mL, 1.6% of brain volume. Hematoma expansion occurred in 7 of 22 (32%). Median expansion was 4 mL (interquartile range, 1-11 mL). Three children had significant (>33%) expansion; 2 required urgent hematoma evacuation. Expansion was not associated with poorer outcome. Compared with children with only 1 head CT scan within 48 hours, children with 2 head CT scans had larger baseline hemorrhage volumes (P = .05) and were more likely to receive treatment for elevated intracranial pressure (P < .001). CONCLUSIONS AND RELEVANCE: Hematoma expansion occurs in children with intracerebral hemorrhage and may require urgent treatment. Repeat CT should be considered in children with either large hemorrhage or increased intracranial pressure.
IMPORTANCE: Hematoma expansion is the only modifiable predictor of outcome in adult intracerebral hemorrhage; however, the frequency and clinical significance of hematoma expansion after childhood intracerebral hemorrhage are unknown. OBJECTIVE: To assess the frequency and extent of hematoma expansion in children with nontraumatic intracerebral hemorrhage. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational cohort study at 3 tertiary care pediatric hospitals. Children (≥ 37 weeks' gestation to 18 years) with nontraumatic intracerebral hemorrhage were enrolled in a study from 2007 to 2012 focused on predictors of outcome. For this planned substudy of hematoma expansion, neonates 28 days or younger and participants with isolated intraventricular hemorrhage were excluded. Children with 2 head computed tomography (CT) scans within 48 hours were evaluated for hematoma expansion and were compared with children with only 1 head CT scan. Consent for the primary cohort was obtained from 73 of 87 eligible participants (84%); 41 of 73 children enrolled in the primary cohort met all inclusion/exclusion criteria for this substudy, in whom 22 had 2 head CT scans obtained within 48 hours that could be evaluated for hematoma expansion. Within our substudy cohort, 21 of 41 (51%) were male, 25 of 41 (61%) were white, 16 of 41 (39%) were black, and median age was 7.7 years (interquartile range, 2.0-13.4 years). MAIN OUTCOME AND MEASURE: Primary outcome was prevalence of hematoma expansion. RESULTS: Of 73 children, 41 (56%) met inclusion criteria, and 22 (30%) had 2 head CT scans to evaluate expansion. Among these 22 children, median time from symptom onset to first CT was 2 hours (interquartile range, 1.3-6.5 hours). Median baseline hemorrhage volume was 19.5 mL, 1.6% of brain volume. Hematoma expansion occurred in 7 of 22 (32%). Median expansion was 4 mL (interquartile range, 1-11 mL). Three children had significant (>33%) expansion; 2 required urgent hematoma evacuation. Expansion was not associated with poorer outcome. Compared with children with only 1 head CT scan within 48 hours, children with 2 head CT scans had larger baseline hemorrhage volumes (P = .05) and were more likely to receive treatment for elevated intracranial pressure (P < .001). CONCLUSIONS AND RELEVANCE: Hematoma expansion occurs in children with intracerebral hemorrhage and may require urgent treatment. Repeat CT should be considered in children with either large hemorrhage or increased intracranial pressure.
Authors: Lauren A Beslow; Rebecca N Ichord; Scott E Kasner; Michael T Mullen; Daniel J Licht; Sabrina E Smith; Phillip B Storm; Lori C Jordan; Steven R Messé Journal: Stroke Date: 2010-02-24 Impact factor: 7.914
Authors: D Rodriguez-Luna; M Rubiera; M Ribo; P Coscojuela; S Piñeiro; J Pagola; M Hernandez-Guillamon; B Ibarra; F Romero; J Alvarez-Sabin; J Montaner; C A Molina Journal: Neurology Date: 2011-10-12 Impact factor: 9.910
Authors: Candice Delcourt; Yining Huang; Hisatomi Arima; John Chalmers; Stephen M Davis; Emma L Heeley; Jiguang Wang; Mark W Parsons; Guorong Liu; Craig S Anderson Journal: Neurology Date: 2012-06-27 Impact factor: 9.910
Authors: Lauren A Beslow; Nicholas S Abend; Melissa C Gindville; Rachel A Bastian; Daniel J Licht; Sabrina E Smith; Argye E Hillis; Rebecca N Ichord; Lori C Jordan Journal: JAMA Neurol Date: 2013-04 Impact factor: 18.302
Authors: Gregoire Boulouis; Ellis S van Etten; Andreas Charidimou; Eitan Auriel; Andrea Morotti; Marco Pasi; Kellen E Haley; H Bart Brouwers; Alison M Ayres; Anastasia Vashkevich; Michael J Jessel; Kristin M Schwab; Anand Viswanathan; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein; M Edip Gurol Journal: JAMA Neurol Date: 2016-12-01 Impact factor: 18.302
Authors: Ramy Alloush; Nahed Salah Eldin; Hala El-Khawas; Rania Shatla; Maha Nada; Maha Z Mohammed; Adel Alloush Journal: Egypt J Neurol Psychiatr Neurosurg Date: 2022-07-07